Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04817969 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Persona Ti-Nidium Post-Market Clinical Follow-up

Study acronym: TKA
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Eligibility criteria expanded, about 24 words Secondary endpoints: details revised at 2 of 2 entries · Site details revised at 1 of 7 sites · Study description expanded, about 2 words Show 3 more changesShow less
    • Secondary endpoints: details revised at 2 of 2 entries
    • Site details revised at 1 of 7 sites
    • Study description expanded, about 2 words
  2. 4 versions Re-verified since Dec 19, 2024, no change to tracked fieldsv8-v11
  3. Trial status: Recruiting to Active, Not Recruiting Site details revised at 7 of 7 sitesv7 Show 1 more changeShow less
    • Site details revised at 7 of 7 sites
  4. Study sites: 6 to 7v6
  5. Study sites: 3 to 6v5
Show 3 earlier versionsHide 3 earlier versions
  1. Study sites: 2 to 3v4
  2. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 2 · Start date changed from estimate of May 2021 to Jun 1, 2021v3 Show 2 more changesShow less
    • Study sites: 0 to 2
    • Start date changed from estimate of May 2021 to Jun 1, 2021
  3. Primary endpoint revised Secondary endpoints: details revised at 2 of 2 entriesv2 Show 1 more changeShow less
    • Secondary endpoints: details revised at 2 of 2 entries

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main objectives of this study are to evaluate overall clinical performance and safety of the Persona Ti-Nidium implant in total knee arthroplasty.
Trial Details
NCT Number NCT04817969
Lead Sponsor Zimmer Biomet
Conditions Knee Pain Chronic, Osteoarthritis, Rheumatoid Arthritis, Traumatic Arthritis, Polyarthritis, Varus Deformity, Valgus Deformity, Flexion Deformity of the Knee +2 more
Enrollment 240 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov